Drugs / NNC9204-1513
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03444467 | Feb → May 2018 | type 1 diabetes mellitus, type 2 diabetes mellitus | Novo Nordisk A/S | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NNC9204-1513 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03444467 ↗ |
| Route | Subcutaneous | “NNC9204-1513 subcutaneous (s.c., in to a skin fold on the stomach) injection” NCT03444467 ↗ |